Semaglutide showed 14.9% at 68 weeks (phase 3, STEP 1)
Topical tirzepatide generally refers to tirzepatide delivered through the skin rather than by injection
After the initial treatment phase, maintenance sessions are often recommended to preserve skin brightening and wellness benefits over time
While many drugs in this class were initially approved to treat type 2 diabetes, they have also been approved for weight loss
Yet Medicaid drug coverage is much rarer for patients using Ozempic for weight loss, since its not an approved use
Summary: Feeling faint on Ozempic typically results from dehydration due to gastrointestinal side effects, reduced fluid intake, blood pressure changes, or hypoglycaemia when combined with insulin or sulfonylureas